Published in J Thorac Cardiovasc Surg on December 14, 2009
Retracted Long-Term Follow-Up Results From PET/CT Surveillance After Surgical Resection of Lung Adenocarcinoma Manifesting as Ground-Glass Opacity. Medicine (Baltimore) (2016) 1.42
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients. Interact Cardiovasc Thorac Surg (2012) 0.89
PET/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer. Am J Nucl Med Mol Imaging (2013) 0.87
Post-therapeutic positron emission tomography/computed tomography for early detection of non-small cell lung cancer recurrence. Transl Lung Cancer Res (2013) 0.79
Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients. J Nucl Med (2014) 0.78
Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection. J Thorac Dis (2016) 0.75
Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Lung Cancer (2016) 0.75
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography. Lung Cancer (Auckl) (2016) 0.75
Planned FDG PET-CT Scan in Follow-Up Detects Disease Progression in Patients With Locally Advanced NSCLC Receiving Curative Chemoradiotherapy Earlier Than Standard CT. Medicine (Baltimore) (2015) 0.75
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. J Thorac Oncol (2010) 1.43
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer (2009) 1.22
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet (2007) 1.20
Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer (2007) 0.99
Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer. Surg Endosc (2010) 0.95
EML4-ALK fusion gene in Korean non-small cell lung cancer. J Korean Med Sci (2012) 0.93
Primary esophageal repair in Boerhaave's syndrome. Dis Esophagus (2008) 0.92
Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.90
Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer. Cancer Sci (2010) 0.90
AKT1 polymorphisms and survival of early stage non-small cell lung cancer. J Surg Oncol (2011) 0.90
O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol Carcinog (2006) 0.88
Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer (2002) 0.87
Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer. Cancer Sci (2010) 0.87
A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer. J Thorac Oncol (2012) 0.86
A functional variant at 19q13.3, rs967591G>A, is associated with shorter survival of early-stage lung cancer. Clin Cancer Res (2013) 0.85
Intramural hematoma of gastric tube after Ivor Lewis operation. Ann Thorac Surg (2010) 0.83
Management of primary and secondary pneumothorax using a small-bore thoracic catheter. Interact Cardiovasc Thorac Surg (2010) 0.83
Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population. Cancer Detect Prev (2006) 0.81
Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study. J Korean Med Sci (2009) 0.81
The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations. Mol Carcinog (2013) 0.78
No association between polymorphisms in the histone deacetylase genes and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.78
Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma. J Thorac Oncol (2010) 0.77
Polymorphisms in apoptosis-related genes and TP53 mutations in non-small cell lung cancer. J Korean Med Sci (2011) 0.75
Thoracoscopic repair of cervical lung hernia. J Thorac Cardiovasc Surg (2002) 0.75